stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Maxcyte IncMXCT
$1.201.69%0.02

Maxcyte Inc (MXCT)

Maxcyte Inc stock is traded at $1.20, with a volume of 191,237. It is up +1.69% in the last 24 hours and down -7.69% over the past month. MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Previous Close:
$1.18
Open:
$1.19
24h Volume:
191,237
Relative Volume:
0.11
Market Cap:
$123.90M
Revenue:
$32.29M
Net Income/Loss:
-$39.12M
P/E Ratio:
-
EPS:
-$0.3669
Net Cash Flow:
-$29.51M
1W Performance:
+6.19%
1M Performance:
-7.69%
6M Performance:
+15.38%
1Y Performance:
-26.38%
1-Day Range:
$1.18$1.26
1-Week Range:
$1.02$1.28
52-Week Range:
$0.6434$1.81

Maxcyte Inc Stock (MXCT) Company Profile

Name
Maxcyte Inc
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE, USA
Employee
91
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
MXCT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Maxcyte Inc Stock (MXCT) Financials Data

Similar to MXCT